Vitamin C Makers Tell 2nd Circ. To Uphold Chinese Law

Law360, New York (July 22, 2014, 3:13 PM EDT) -- North China Pharmaceuticals Group Corp. and HeBei Welcome Pharmaceuticals Co. on Monday told the Second Circuit that reversal of a verdict against them in a vitamin C price-fixing class action was necessary because the purchasers who brought the suit admitted that the companies’ coordination was required by Chinese law.

NCPG and HeBei, which were replying to the purchasers’ opposition brief, further supported their April appellate petition by arguing that an affirmation of a New York federal jury’s $153 million verdict would lead to a sea of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re Vitamin C Antitrust Liti


Case Number

13-4791

Court

Appellate - 2nd Circuit

Nature of Suit

3410 STATUTES-Antitrust

Date Filed

December 23, 2013

Law Firms

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.